Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Condition:   Gorlin Syndrome Interventions:   Drug: Patidegib Topical Gel;   Drug: Vehicle Gel Sponsors:   Sol-Gel Technologies, Ltd.;   Premier Research Group plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials